Literature DB >> 28991244

Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk.

A Re1, G Gini2, M Rupolo3, A Levis4, A Bandera5, A M Liberati6, P Tozzi1, C Cattaneo1, S Casari7, C Skert8, C Bocci2, M Spina9, B Allione10, L Verga11, M Michieli3, C Almici12, P F Leali13, U Tirelli9, G Rossi1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28991244     DOI： 10.1038/bmt.2017.230

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.

Authors:  François Boué; Jean Gabarre; Christian Gisselbrecht; Jacques Reynes; Antoine Cheret; Fabrice Bonnet; Eric Billaud; Martine Raphael; Remi Lancar; Dominique Costagliola
Journal:  J Clin Oncol       Date:  2006-08-08       Impact factor: 44.544

Review 2.  HIV protease inhibitors impact on apoptosis.

Authors:  Stacey A Rizza; Andrew D Badley
Journal:  Med Chem       Date:  2008-01       Impact factor: 2.745

3.  High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors.

Authors:  Alessandro Re; Mariagrazia Michieli; Salvatore Casari; Bernardino Allione; Chiara Cattaneo; Maurizio Rupolo; Michele Spina; Rosa Manuele; Emanuela Vaccher; Mario Mazzucato; Luciano Abbruzzese; Pierino Ferremi; Giampiero Carosi; Umberto Tirelli; Giuseppe Rossi
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

Review 4.  Anti-HIV drugs for cancer therapeutics: back to the future?

Authors:  Warren A Chow; Chunling Jiang; Min Guan
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

5.  Autologous stem cell transplantation for HIV-associated lymphoma.

Authors:  A Krishnan; A Molina; J Zaia; A Nademanee; N Kogut; J Rosenthal; D Woo; S J Forman
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

6.  Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.

Authors:  Josep-Maria Ribera; Albert Oriol; Mireia Morgades; Eva González-Barca; Pilar Miralles; Armando López-Guillermo; Santiago Gardella; Andres López; Eugenia Abella; Marta García
Journal:  Br J Haematol       Date:  2007-12-19       Impact factor: 6.998

7.  Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

Authors:  Joseph C Alvarnas; Jennifer Le Rademacher; Yanli Wang; Richard F Little; Gorgun Akpek; Ernesto Ayala; Steven Devine; Robert Baiocchi; Gerard Lozanski; Lawrence Kaplan; Ariela Noy; Uday Popat; Jack Hsu; Lawrence E Morris; Jason Thompson; Mary M Horowitz; Adam Mendizabal; Alexandra Levine; Amrita Krishnan; Stephen J Forman; Willis H Navarro; Richard Ambinder
Journal:  Blood       Date:  2016-06-13       Impact factor: 22.113

8.  Autologous stem-cell transplantation in patients with HIV-related lymphoma.

Authors:  Pascual Balsalobre; José L Díez-Martín; Alessandro Re; Mariagrazia Michieli; José M Ribera; Carmen Canals; Anne Rosselet; Eulogio Conde; Rosario Varela; Kate Cwynarski; Ian Gabriel; Philippe Genet; Gaelle Guillerm; Bernardino Allione; Augustin Ferrant; Pierre Biron; Ildefonso Espigado; David Serrano; Anna Sureda
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.

Authors:  José L Díez-Martín; Pascual Balsalobre; Alessandro Re; Mariagrazia Michieli; José M Ribera; Carmen Canals; Eulogio Conde; Anne Rosselet; Ian Gabriel; Rosario Varela; Bernardino Allione; Kate Cwynarski; Philippe Genet; Ildefonso Espigado; Pierre Biron; Norbert Schmitz; Anne E Hunter; Augustin Ferrant; Gaelle Guillerm; Mark Hentrich; Manuel Jurado; Pascual Fernández; David Serrano; Giuseppe Rossi; Anna Sureda
Journal:  Blood       Date:  2009-03-23       Impact factor: 22.113

10.  B- and T-lymphocyte number and function in HIV+/HIV- lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation.

Authors:  Diego Bertoli; Alessandro Re; Marco Chiarini; Alessandra Sottini; Federico Serana; Viviana Giustini; Aldo M Roccaro; Chiara Cattaneo; Luigi Caimi; Giuseppe Rossi; Luisa Imberti
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379
View more
  2 in total

1.  Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.

Authors:  Polina Shindiapina; Maciej Pietrzak; Michal Seweryn; Eric McLaughlin; Xiaoli Zhang; Mat Makowski; Elshafa Hassan Ahmed; Sarah Schlotter; Rebecca Pearson; Rhonda Kitzler; Anna Mozhenkova; Jennifer Le-Rademacher; Richard F Little; Gorgun Akpek; Ernesto Ayala; Steven M Devine; Lawrence D Kaplan; Ariela Noy; Uday R Popat; Jack W Hsu; Lawrence E Morris; Adam M Mendizabal; Amrita Krishnan; William Wachsman; Nita Williams; Nidhi Sharma; Craig C Hofmeister; Stephen J Forman; Willis H Navarro; Joseph C Alvarnas; Richard F Ambinder; Gerard Lozanski; Robert A Baiocchi
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

2.  Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis.

Authors:  Thanh Truong Giang Ly; Jisoo Yun; Jong-Seong Ha; Yeon-Ju Kim; Woong-Bi Jang; Thi Hong Van Le; Vinoth Kumar Rethineswaran; Jaewoo Choi; Jae-Ho Kim; Sang-Hyun Min; Dong-Hyung Lee; Ju-Seok Yang; Joo-Seop Chung; Sang-Mo Kwon
Journal:  Int J Mol Sci       Date:  2022-01-15       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.